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Abstract 
 Introduction: Carcinoid tumors are rare tumors that are defined as a slow-growing neuroendocrine tumor. They are very 
rare in ovaries. They can be primarily of ovarian origin or may be found as metastatic lesions in ovaries.  
Presentation of Case: A 67-year-old postmenopausal woman presented with vaginal bleeding. Her transvaginal 
ultrasonography revealed a smooth-contoured solid mass of 8.5x6 cm in right adnexal region. Total abdominal 
hysterectomy with bilateral salpingo-oophorectomy was performed. Postoperative histopathological examination revealed 
pure ovarian insular carcinoid tumor. No chemotherapy or radiotherapy was applied. No residual or recurrent pathology 
was observed during follow-ups for 3 years following the operation.  
Conclusion: Carcinoid tumors may rarely be as pure tumors. The histopathological diagnosis is challenging. Surgical 
therapy is the only option, and chemotherapy and radiotherapy have no role in management of these tumors. 
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Introduction 
Carcinoid tumors are rare tumors of 
neuroendocrine origin, which may be localized in 
all organs. They are characterized by production of 
various polypeptides and biogenic amino acids [1]. 
Although they mostly originate from 
gastrointestinal system (80%), they also rarely 
arise from bile ducts, bronchi, ovaries and 
presacral area [2,3]. They are also called 
neuroendocrine tumors.  
Primary ovarian carcinoid tumors are rare 
ovarian neoplasm. They constitute 0.1% of all 
ovarian neoplasias and 0.3% of all carcinoid 
tumors [4]. They can be usually seen with a 
dermoid cyst, mucinous cystadenoma, 
Sertoli-Leydig cell tumor, or Brenner tumor. Pure 
forms are extensively rare. We considered our 
case worth reporting since it is a very rare case 
owing to the absence of any other accompanying 
tumor and the challenges that we went through 
during the diagnostic steps. We herein 
summarized histopathological and clinical 
characteristics of our case.   
Case Presentation 
A 67-year-old woman, having gravidity 4, parity 3, 
who was in menopause for 6 years, presented to 
our gynecology clinic with vaginal bleeding. She 
had no characteristic symptoms suggestive of 
carcinoid syndrome, such as flushing or diarrhea. 
Her past medical history was not remarkable 
except for morbid obesity (BMI 41) and 
hypertension. Her transvaginal ultrasonography 
revealed a smooth-contoured solid mass with a 
size of 8.5x6 cm in right adnexal region. An 
endometrial and cervical diagnostic curettage were 
performed. The endometrial pathology report 
returned with a diagnosis of endometrial 
hyperplasia without simple atypia. Serum tumor 
markers (CA-125, CA-19.9) were in normal limits. 
As the patient had postmenopausal bleeding and 
adnexal mass, an operation was scheduled. During 
the operation it was noted that uterus was of 
normal size. However, a mobile, solid, 
yellow-light brown color tumor free from 
surrounding tissues was observed in the right 
adnexal region. No abdominal free fluid was 
present. The right adnexal mass was removed and 
sent for frozen examination. The frozen report 
returned with a malignant diagnosis, prompting us 
to complete the operation to total abdominal 
hysterectomy, left salphingo-oophorectomy, 
paraaortic lymph node dissection, omentectomy, 
and appendectomy. Histopathological examination 
of the mass revealed acinary and cribriform 
structures formed by cells with a large, pink 
cytoplasm and round-uniform nuclei. Luminal 
pink-amorphous structures were also noted in 
some areas. No necrosis was observed, and also no 
mitosis was detected under 10 magnification field 
(Figure 1).    
Immunohistochemical examination 
demonstrated tumor cells that were synaptophysin 
(+), chromogranin (+), pan-cytokeratin (+) and 
cytokeratin 20 focal-weak positive. Inhibin, 
vimentin, CD56, cytokeratin 7, and CD99 were 
found negative. Ki-67 proliferation index was 
below 1%. Under the light of these data the case 
was considered to be a pure ovarian insular 
carcinoid tumor. Following the operation the 
surgical stage of the patient was determined as the 
stage 1 according to International Federation of 
Obstetricians and Gynaecologists (FIGO) Staging 
System for Ovarian Cancer [5].  
The patient attended regular follow-ups for 3 years 
after the surgery. No chemotherapy or 
radiotherapy was applied. No recurrent pathology 
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was observed at follow-ups. 
 
 
 
 
 
 
 
 
 
 
 
(a)                                    (b) 
 
 
 
 
 
 
 
 
 
 
(c)                                    (d) 
Figure 1 (a) The microphotographs show a pure ovarian insular carcinoid tumor. They show monotonous tumor 
cells forming islets and layers ( H&Ex10 ) ; (b)Under greater magnification,  monotony, narrow cytoplasm, and 
salt-pepper type chromatin of the tumor cells are noted ( H&Ex40); (c)In immunohistochemical examination the 
tumor cells were diffusely positive for pan-cytokeratin (Pan-cytokeratin x10); (d)In immunohistochemical 
examination the tumor cells were diffusely positive for cytoplasmic synaptophysin (Synaptophysin x20). 
 
Discussion 
Primary ovarian carcinoid tumor is usually 
one-sided and seen in peri or postmenopausal 
women [6]. They develop from 
well-differentiated neuroendocrine cells. They 
have different histological subtypes as insular, 
trabecular, stromal and mucinous [6]. The 
primary trabecular form is the least common type. 
It usually grows slowly, does not produce a 
carcinoid syndrome, does not metastasize, and 
has a favorable prognosis [7]. The primary 
mucinous carcinoid tumor is usually unilateral 
and has a more aggressive course compared to 
other subtypes [2]. The primary stromal 
carcinoid is the rarest form. The primary insular 
form, on the other hand, is the commonest type, 
which is observed with ovarian teratomas in far 
less than 1% of cases and constitutes slightly less 
than 1% of all carcinoid tumors [8,9]. Patients 
with primary ovarian carcinoid tumors may 
present with symptoms of carcinoid syndrome 
including skin changes (redness in face and neck, 
telangiectasia), diarrhea, sensation of warmth, 
abdominal pain, cardiovascular pathologies 
(pulmonary stenosis, tricuspid insufficiency, and 
tricuspid stenosis), and pulmonary abnormalities 
(asthmatic attacks) [10,11]. Carcinoid syndrome 
is observed approximately one third of ovarian 
carcinoid cases [12]. This syndrome has been 
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reported at a rate of 43% in insular type, and 
25% of these cases were noted to originate from 
mature cystic teratomas [7,12]. Although our 
patient had a tumor of the insular type, she had 
no symptoms compatible with carcinoid 
syndrome.  
Ovarian carcinoid tumors can be usually seen 
with dermoid cyst, mucinous cystadenoma, 
Sertoli-Leydig cell tumor, or Brenner tumor. Pure 
forms are rare, grow slowly, and have a low 
malignancy potential. An immunohistochemical 
staining positive for argentaffin, argyrophil, and 
chromogranin A as well as the presence of 
cytoplasmic neurosecretory granules supports the 
diagnosis of ovarian carcinoid tumors. Despite 
these unique microscopic properties, they may be 
confused with various distinct ovarian tumors 
including granulosa cell tumor, Sertoli-Leydig 
cell tumor, Brenner tumor, and metastatic 
carcinoid ovarian tumor [13]. 5-HIAA, the main 
serotonin metabolite, is increased in urine. 
5-HIAA is eliminated from urine and serum 
serotonin level markedly decreases with removal 
of tumor. It is important that the course of the 
disease is monitored with serum serotonin and 
urinary 5-HIAA levels [14]. 
The malignancy potential of ovarian primary 
insular carcinoid tumors should not be overlooked, 
even though they grow very slowly. They are 
usually diagnosed at FIGO stage 1 [15]. Literature 
reports have given a survival rate of 100% in the 
primary form limited to one ovary whereas it 
drops to 35% at advanced stage. In contrast, 
metastatic forms have a more aggressive course 
[2]. Bilateral salphingo-oophorectomy and total 
abdominal hysterectomy are the treatments of 
choice at pre-and postmenopausal state, while 
unilateral salphingo-oophorectomy usually 
suffices for younger patients [16].    
 
It is crucial to distinguish primary versus 
secondary ovarian carcinoid tumors. Carcinoid 
tumors originating from gastrointestinal system 
particularly metastasize to ovaries and they are 
generally bilateral. In contrast, primary ovarian 
carcinoid tumors are unilateral.  
Conclusion 
Ovarian pure carcinoid tumors are rare. 
Differential diagnosis may pose difficulty for the 
pathologist. Such patients are usually diagnosed at 
FIGO stage 1. They have a low malignancy 
potential. Unlike many ovarian tumors, surgery is 
usually sufficient for the treatment of ovarian 
carcinoid tumors and preoperative and 
postoperative chemotherapy is not needed. 
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